Patient-reported outcomes and experiences with COMT inhibitors in the management of motor fluctuations in Parkinson&#39;s disease: a UK-based nested cross-sectional study.

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

Comtan (entacapone) - Novartis, Orion Corp

http://www.ncbi.nlm.nih.gov/pubmed/42033513

Alastair J Noyce; Emma-Louise Shelton; Glynn Harrison-Jones; Lara Akindele; María Teresa Periñán; Mario Ippolito; Olina Efthymiadou; Raquel Maio

Apr 26, 2026